Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

Idiopathic intracranial hypertension (IIH), formerly called pseudotumor cerebri, is a condition of elevated pressure inside the skull without an identifiable cause like a tumor or blood clot. The increased pressure can damage the optic nerves and cause vision loss if untreated.

Your IIH Patient Journey

For comprehensive guidance on living with IIH—from diagnosis through long-term management, including medication tips, vision monitoring, and when surgery may be needed—see our complete patient guide: Your IIH Journey - Diagnosis to Long-Term Management.

Understanding IIH

In IIH, cerebrospinal fluid (CSF)—the fluid cushioning the brain—is produced normally but doesn't drain efficiently. This causes pressure to build up, affecting the brain and particularly the optic nerves where they enter the skull.

The condition is called:

• Idiopathic—no identified cause
• Intracranial hypertension—high pressure inside the skull
• Pseudotumor cerebri—old name meaning "false brain tumor" (mimics tumor symptoms)

Symptoms

Headache

• Most common symptom
• Often daily, throbbing
• Worse in morning
• Worse with straining, coughing, bending
• May improve after vomiting
• May be triggered by lying down

Visual Symptoms

• Transient visual obscurations—brief (seconds) dimming or graying of vision
• Often triggered by position change or straining
• Visual field loss—may be gradual and unnoticed
• Blurred vision
• Double vision—from sixth nerve palsy

Other Symptoms

• Pulsatile tinnitus—whooshing sound in ears synchronized with heartbeat
• Neck and shoulder pain
• Nausea
• Cognitive difficulties ("brain fog")

Who Gets IIH?

Classic Demographic

• Women of childbearing age (15-44 years)
• Overweight or recent weight gain
• 20 times more common in obese women
• Can occur in men and children (less common)

Associated Factors

• Obesity (most important risk factor)
• Recent weight gain
• Certain medications (tetracyclines, vitamin A/retinoids, growth hormone)
• Venous sinus stenosis (narrowing)
• Sleep apnea

Diagnosis

Fundoscopic Examination

• Papilledema—swelling of the optic discs
• Key finding that raises suspicion for IIH
• Severity correlates with risk of vision loss

Visual Field Testing

• Detects vision loss that patient may not notice
• Often shows enlarged blind spot
• May show peripheral constriction
• Essential for monitoring

Brain Imaging

• MRI brain with MRV—required to rule out other causes
• May show: empty sella, flattened back of eyeballs, enlarged optic nerve sheaths, venous sinus stenosis
• Rules out tumors, blood clots, other structural causes

Lumbar Puncture (Spinal Tap)

• Confirms elevated pressure—typically >25 cm H2O (often higher)
• CSF composition is normal
• May provide temporary relief of symptoms
• Required for diagnosis

Optical Coherence Tomography (OCT)

• Measures optic nerve fiber layer thickness
• Tracks papilledema over time
• Detects early nerve damage

Diagnostic Criteria (Modified Dandy)

1. Symptoms of elevated intracranial pressure (headache, vision symptoms)
2. Papilledema present
3. Normal neurological exam (except cranial nerve VI palsy)
4. Normal brain imaging (MRI/MRV)
5. Elevated CSF pressure on lumbar puncture
6. Normal CSF composition

Treatment

Weight Loss

• Most effective long-term treatment
• 5-10% weight loss can significantly improve symptoms
• May lead to complete resolution
• Bariatric surgery may be considered for severe obesity

Medications

Acetazolamide (Diamox)

• First-line medication
• Reduces CSF production
• Start low, increase gradually
• Side effects: tingling, carbonated drinks taste flat, kidney stones

Topiramate (Topamax)

• Alternative or addition to acetazolamide
• May help with headache
• Can cause weight loss (advantage in IIH)
• Side effects: cognitive slowing, tingling

Furosemide

• Sometimes added to acetazolamide
• Monitor potassium

GLP-1 Receptor Agonists (Emerging Treatment)

GLP-1 medications (such as semaglutide, sold as Ozempic or Wegovy) are showing significant promise for IIH. Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways:

1. Weight loss — the most effective long-term treatment for IIH
2. Direct CSF pressure reduction — GLP-1 receptors on the choroid plexus (where CSF is made) reduce fluid secretion independent of weight loss

The IIH Pressure Trial (Brain, 2023) found that exenatide reduced headache days by 7.7 per month compared to 1.5 for placebo, with intracranial pressure dropping within hours of the first dose. A large retrospective study of over 44,000 IIH patients (JAMA Neurology, 2025) found that GLP-1 users had significantly lower rates of papilledema, headache, and visual disturbances.

GLP-1 medications are not yet standard of care for IIH, and more research is needed. For a detailed review of the evidence, see our guide on GLP-1 medications and eye health.

Procedures

Serial lumbar punctures

• Temporary relief of pressure
• Not a long-term solution
• May be used while medications take effect

Surgery (for severe or progressive cases)

Optic nerve sheath fenestration

• Creates window in optic nerve covering
• Protects vision
• May not help headache

Shunting procedures

• Ventriculoperitoneal (VP) shunt or lumboperitoneal shunt
• Drains excess CSF
• Helps both vision and headache
• May need revision over time

Venous sinus stenting

• For patients with venous sinus stenosis
• May reduce pressure
• Specialized centers

Monitoring

Regular follow-up is essential:

• Visual field testing—every few months or more often if unstable
• OCT—tracks nerve fiber layer
• Clinical exam—checking papilledema
• Symptom assessment
• Weight monitoring

Prognosis

Good Outcomes

• Most patients have good visual outcomes with treatment
• Symptoms often improve or resolve
• Weight loss can lead to long-term remission

Concerns

• Without treatment, progressive vision loss can occur
• Vision loss may be permanent
• May recur, especially with weight regain
• Requires ongoing monitoring

Frequently Asked Questions

Is IIH the same as a brain tumor?

No. The old name "pseudotumor cerebri" meant it mimics tumor symptoms, but there's no actual tumor. IIH is caused by elevated CSF pressure without a structural cause.

Will I go blind from IIH?

Without treatment, progressive vision loss can occur. However, with proper monitoring and treatment, most people maintain good vision. This is why regular visual field testing is so important.

Do I have to lose weight?

Weight loss is the most effective long-term treatment for IIH in overweight patients. Even modest weight loss (5-10%) can significantly improve the condition. Medications can help but work best combined with weight management.

Can IIH be cured?

Many people achieve remission, especially with significant weight loss. However, the condition can recur, particularly with weight regain. Some people need long-term medication or surgery.

Why do I have double vision?

The elevated pressure can stretch the sixth cranial nerve, which controls outward eye movement. This is usually temporary and improves as pressure is controlled.

How long do I need to take medication?

It varies. Some people can taper off after weight loss and stabilization. Others need long-term treatment. Your doctor will guide tapering based on your response.

What does an IIH headache feel like?

The typical IIH headache is daily, throbbing, and often worse in the morning or when lying down. It frequently worsens with straining, coughing, or bending. Many patients also experience transient visual obscurations—brief episodes of vision going gray or dark—alongside the headache. Unlike migraines, IIH headaches are usually accompanied by papilledema and may improve temporarily after a lumbar puncture.

Can I exercise with IIH?

Yes, regular exercise is generally safe and encouraged because it supports weight loss—the most effective long-term treatment for IIH. Light to moderate aerobic exercise (walking, swimming, cycling) is ideal. However, avoid heavy Valsalva maneuvers such as straining during heavy weightlifting, as these can transiently raise intracranial pressure. Listen to your body and discuss an exercise plan with your doctor.

Does IIH cause brain fog or cognitive problems?

Yes. Many IIH patients report cognitive difficulties including problems with concentration, memory, and mental processing speed. Research has documented these cognitive effects, and they can significantly impact daily life and work. The good news is that cognitive symptoms often improve as intracranial pressure is brought under control with treatment and weight loss.

Is IIH a disability?

IIH can qualify as a disability depending on the severity of your symptoms and how they affect your ability to work. Studies suggest that IIH impacts work capacity in approximately 48% of patients. Vision loss, chronic headaches, and cognitive difficulties may all limit daily functioning. If your condition significantly affects your ability to work, you may be eligible for disability accommodations or benefits—discuss this with your healthcare provider and employer.

Can IIH come back after treatment?

Yes. Recurrence rates range from 23-38% in studies, and weight regain is the most common trigger. This is why maintaining a healthy weight after achieving remission is so important. Continued monitoring—including periodic visual field testing and eye exams—is recommended even after stopping medication, so any recurrence can be caught early before vision is affected.

What is pulsatile tinnitus and is it related to IIH?

Pulsatile tinnitus is a rhythmic whooshing or pulsing sound in one or both ears that synchronizes with your heartbeat. It is caused by turbulent blood flow near the ear, which becomes audible when intracranial pressure is elevated. Pulsatile tinnitus is one of the hallmark symptoms of IIH and often improves as pressure is lowered with treatment. If you develop pulsatile tinnitus, it should be evaluated by a doctor.

Are GLP-1 medications like Ozempic being used to treat IIH?

GLP-1 receptor agonists are emerging as a promising treatment for IIH, with research showing they can reduce intracranial pressure through both weight loss and direct effects on CSF production. The IIH Pressure Trial showed significant reductions in headache days, and a large study of over 44,000 patients found better outcomes across multiple measures. However, they are not yet standard of care. Learn more in our comprehensive guide to GLP-1 medications and eye health.

References